Bezitramide

DB01459ApprovedIllicitWithdrawnSmall molecule

Bezitramide is a narcotic analgesic which was discovered in 1961, clinically tested around the 1970's , and marketed under the name Burgodin. After cases of fatal overdose in the Netherlands... Bezitramide has never been FDA approved and is currently a schedule II drug.

Chemical structure of Bezitramide
Primary indication
A narcotic analgesic once used for the treatment of severe chronic pain.Curator reviewed
Formula / weight
C31H32N4O2 · 492.6114 g/mol (avg)
Code names
IDS-NB-007 · R-4845

Resolves to

Compound
UNII3KXW0Y310ICAS15301-48-1ChEMBLCHEMBL2104149ChEBI135794PubChem61791
Clinical / RWD
ATCN02AC05
Structure
InChIKeyFLKWNFFCSSJANB-UHFFFAOYSA-NSMILESCCC(=O)N1C(=O)N(C2CCN(CCC(C#N)(C3=CC=CC=C3)C3=CC=CC=C3)CC2)C2=CC=CC=C12

What you can answer from here — as of September 13, 2026

624Drug interactionsStructured to mechanism, not free text
Sign in
1ATC codeIncluding every combination product, plus 9 drug categories
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which companies are running trials of Bezitramide, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In